MedTrace Logo

Vitamin D, Omega-3, and Combination Vitamins B, C and Zinc Supplementation for the Treatment and Prevention of COVID-19

NCT04828538 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-11-08

No results posted yet for this study

Summary

The NUTROVID Factorial Trials

The purpose of the NUTROVID-Prevent and NUTROVID-Treat Factorial Trials is to determine whether Vitamin B Complex, Vitamin C, and Zinc; Vitamin D; and Omega3, taken at dosages approximating recommended dosages, can reduce the risk of COVID-19 infection, hospitalization, mortality.

Conditions

  • Covid19

Interventions

DIETARY_SUPPLEMENT

Vitamin D

Daily 4000 IU Vitamin D for 60 days

DIETARY_SUPPLEMENT

Omega DHA / EPA

Daily 1000mg Omega DHA/EPA for 60 days

DIETARY_SUPPLEMENT

Vitamin C, Vitamin B complex and Zinc Acetate

Combination 1000 mg Vitamin C, Vitamin B complex\*\* and Zinc Acetate, 100 mg/day for 60 days \*\*(Vitamin B complex components: B12=1 mg; B6=50 mg; B9=2.5 mg; B1=100 mg; B2=100 mg; B3=14 mg; B7=50 mg)

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • Hospital de la Soledad

    lead OTHER_GOV

Principal Investigators

  • José Yañez · General Hospital Soledad

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04828538 on ClinicalTrials.gov